neurobiology of addiction - ladcp of addiction dr. leo kadehjian palo alto, california molecules...
TRANSCRIPT
1
Neurobiology of Addiction
Dr. Leo Kadehjian
Palo Alto, California
Molecules
Neurons / Cells
Neural Systems
Physiology / Behavior
Geneticsand
Environment
Initiation AbuseDependenceAddiction
Reinforcement
Genetics
Environment
ToleranceSensitization
Withdrawal
Relapse
Craving
Terminology
Reward
2
RewardReinforcement
ToleranceSensitizationDependence
Withdrawal
CravingStress
RelapseNestler and Aghajanian, 1997
! DA
! " Receptor regulation! " 2nd messengers! " Gene expression
! NA, ! Glu, " DA, " 5-HT! Stress factors
Synaptic adaptations ?! Stress factors
Stimulants
Caffeine
Nicotine
CocaineEphedrine
Khat
Amphetamines
MDMA
Opiates
Morphine
Codeine
(Heroin)
(Oxy–, Hydro–)
Methadone, LAAMFentanyls
Meperidine
Sedatives
EthanolBenzodiazepines
Barbiturates
Methaqualone
Hallucinogens
MescalinePsilocybin
(LSD)PCP
Marijuana
Mother Nature vs. Chemists
Neurotransmitters
Amino acids Monoamines Peptides
Glutamate
GABA
Noradrenaline
Dopamine
Serotonin
Acetylcholine
Enkephalins
Substance P
Insulin
Aspartate
Glycine
Histamine
Adrenaline
Many others
100,000 1,000 1::
Oxytocin
Vasopressin
3
MDMA, “Ecstasy”MethamphetamineAmphetamine
NoradrenalineDopamine
NH2
OH
OH
NH2
OH
OH
HO
NH2 HN
HN
OO
Dopamine
Role in reward circuits (1954)
Nicotine, alcohol, marijuanacocaine, morphine, amphetamines
Parkinson’s disease (deficit)
Schizophrenia (excess)
R
R
R
“In this framework, the addicted person’s PFC can no longereven categorize decision problems correctly, much less regaincontrol over the choices that their nervous systems deemvaluable.”
P. Read Montague et al., 2004
Dopamine and Behavioral Control
“In addition, dopamine effects in the PFC may impair theability of the addicted person to suppress prepotent drug-seeking behavior.”
“Because these drugs directly engage dopamine-mediatedreinforcement learning signals, they generate a feedback loopthat reinforces behavior leading to drug consumption,establishing a vicious cycle of action and learning that explainsthe compulsive nature of drug addiction.”
4
HN
HO
l–Ephedrine
HN
HO
d–Pseudoephedrine
NH2
OCH3
OCH3
H3CO
MescalineDopamine
NH2
OH
OH
Noradrenaline
NH2
OH
OH
HO
d–Amphetamine
NH2
d–Methamphetamine
HN
MDMA, “Ecstasy”
HN
OO
NH2
HO
Phenylpropanolamine
HN
CF3
d–Fenfluramine
NH2
Phentermine
NH2
OCH3
l–Cathinone ,“Khat”
HN
OCH3
CH3
Methcathinone, “Cat”
HN
HO
OH
l–Phenylephrine
HN
Propylhexedrine
N
l–Selegiline, Deprenyl
HN
CH3O
O
Ritalin (Methylphenidate)
Serotonin
Generally inhibitory
Role in aggression, violence, suicide,depression, alcoholism, cocaine use
Site of action for LSD, hallucinogens
Neurons damaged by MDMA, fenfluramine
R
R
R
R
NH
HO
NH2
NH
HO
N
NH
H2O3PO
N
NH
NN
O
HO
F3C
HN
Serotonin Bufotenine Psi locybin
ProzacLSD
5
HO
N
HO
O
H3CO
N
HO
O
H3CO
N
O
O
OH
H3CO
N
O
O
HO
N
HO
O
HO
N
O
O
OH
HO
N
O
O
H3CO
N
HO
O
Hydromorphone
Codeine Oxycodone
Morphine
Hydrocodone
Oxymorphone Dihydromorphine
Dihydrocodeine
(Dilaudid) (Numorphan)
(Vicodin, Lortab) (Percodan, OxyContin) (Synalgos)
HO
N
H3CO
O
HO
Buprenorphine
HO
O
HO
N
Morphine
HO
N
O
O
OH
Naltrexone
ReVia, Vivitrol
N
Methadone
O
Treatment
Vaccines ?
Methadone, LAAM
GHB ?
Antagonists
Disulfiram
Naloxone
Agonists
Enzymes ?
Antibodies ?
Buprenorphine
Naltrexone
Anti-craving
Acamprosate
!-vinyl-GABA ?
6
Diabetes
Hypertension
Asthma
Drug Abuse
Heritability
Treatment
Compliance
Relapse
Rates
Drug Dependence, A Chronic Medical Illness
A. McLellan et al., 2000
.8 Type II
.3–.55 Type I
.25–.5
.36–.7
.34 heroin (m)
.55 alcohol (m)
.52 marijuana (f)
.61 nicotine (m,f)
<60% Type I
<40%
<40%
40–60%
30–50% Type I
50–70%
50–70%
40–60%
ICR 25% C57 50% C57 75% C57 C570
20
40
60
80
100Genetics / Cocaine Addiction
E. Ruiz-Durántez et al., 2006Genetic composition
% “ addicted”
Global Speed Memory Verbal Learning Recall Abstract Motor0
10
20
30
40
50
60
70
Extensive metabolizersIntermediate/Poor metabolizers
M. Cherner et al., 2010
CYP2D6 and Methamphetamine Impairments% Impaired
7
Contro
lEtO
H
Red wine
Meth
Meth +
EtOH
Meth +
Red wine
0
200
400
600
800
1000
1200
1400 Dopamine (ng/100 mg tissue)
S. Ali and S. Bondy, 2010
Red Wine Protects Against Methamphetamine Toxicity
Asn40 Asp400%
10%20%30%40%50%60%70%80%90%
100%
PlaceboNaltrexone
µ-Opioid Receptor Genotype and Naltrexone Response
R. Anton et al., 2008
% With good clinical outcome
Adverse childhood environment
MAO-A short vs. long allelles
5HTTLPR * adverse childhood environment
No vs. history of substance abuse
No vs. history of personality disorder
A. Reif et al., 2007
Odds ratio for violence
4.1 (2.6–6.5)
2.3 (1.1–4.7)
0.2 (0.1–0.4)
0.5 (0.2–1.0)
0.9 (0.4–1.9)
Serotonin, Genes, Adverse Childhood Environment, and Violence
8
J
J
H
H
F
F
0
10
20
30
40
50
60
70
0
10
20
30
40
50
60
70
LLSL
SS
SS+SL
Serotonin Transporter Gene, Childhood Environment, and Violence
Adverse childhoodenvironment
No adverse childhoodenvironment
A. Reif et al., 2007
% violence
Epigenetics
Genes, DNA RNA Proteins
Histone methylationHistone acetylation
Inactive geneActive gene
Epigenetics: Histone methylation, acetylation DNA methylation microRNAs transposons, retrotransposons: “jumping genes”
ReceptorsCell functionBehaviors
Stress, bullying
Maternal nurturing
Transient toweeks/months
Methylation, inactive, molecular “scar”,depression< glucocorticoid receptor, increased stress response
Impulsivity Compulsivity
Positive reinforcementdrives behavior
Unplanned reactionswithout regard tonegative consequences
Negative reinforcementdrives behavior
Continued use despiteadverse consequences
9
Impulsivity
Frontal cortexdysfunction
Chronic drug use
Addiction
Prefrontal Cortex Circuits in Addiction
Dorsolateral prefrontal cortex
Orbitofrontal cortex
Anterior cingulate cortex
Impaired inhibition control, impaired decisionmaking
Goal identification, selection, reward processing, guidingbehaviors
Decisionmaking, impulsivity, behavioral disinhibition,drug seeking despite adverse consequences, compulsiverepetitive behaviors
Assessment of consequences, error and conflict detection
R
R
R
J. Feil et al., 2010
Does neuroscience undermine the role of personalresponsibility for development of and recovery from addiction?
n = 231 NAADAC counselors from 44 states
Development: Biofactors even more influential
Recovery: Personal responsibility even more influential (!?)
Examined e!ect of exposure to neuroscience on counselor views
For those with more exposure to neuroscience:
T. Steenbergh et al., 2012
R
R